Unlocking the Therapeutic Potential of BCL-2 Associated Protein Family: Exploring BCL-2 Inhibitors in Cancer Therapy
Article in Biomolecules & Therapeutics (April 2024)
The most recent citing publications are shown below. View all 76 publications that cite this research output on Dimensions.
Piceatannol selectively inhibited the JNK3 enzyme and augmented apoptosis through inhibition of Bcl‐2/Cyt‐c/caspase‐dependent pathways in the oxygen–glucose deprived SHSY‐5Y cell lines: In silico and in vitro study
Article in Chemical Biology & Drug Design (February 2024)
Emerging biomarkers and potential therapeutics of the BCL-2 protein family: the apoptotic and anti-apoptotic context
Article in Egyptian Journal of Medical Human Genetics (January 2024)